verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: nucare pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler nucare pharmaceuticals, inc.
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 240 mg/1

Manufacturer
NuCare Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 66267-212
Product ID 66267-212_1fa6a784-9fb3-c3fa-e063-6394a90add4c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078906
Listing Expiration 2026-12-31
Marketing Start 2009-09-17

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 66267212
Hyphenated Format 66267-212

Supplemental Identifiers

RxCUI
897649
UPC
0366267212908
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA078906 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 240 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-30)
  • 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-90)
source: ndc

Packages (2)

66267-212-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-30) 66267-212-90 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-90)

Ingredients (1)

verapamil hydrochloride (240 mg/1)

Linked Drug Pages (1)

verapamil hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1fa6a784-9fb3-c3fa-e063-6394a90add4c", "openfda": {"upc": ["0366267212908"], "unii": ["V3888OEY5R"], "rxcui": ["897649"], "spl_set_id": ["3f14442c-8178-0bad-e054-00144ff8d46c"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-30)", "package_ndc": "66267-212-30", "marketing_start_date": "20161017"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (66267-212-90)", "package_ndc": "66267-212-90", "marketing_start_date": "20161017"}], "brand_name": "verapamil hydrochloride", "product_id": "66267-212_1fa6a784-9fb3-c3fa-e063-6394a90add4c", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "66267-212", "generic_name": "verapamil hydrochloride", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA078906", "marketing_category": "ANDA", "marketing_start_date": "20090917", "listing_expiration_date": "20261231"}